Join
Live feed
·
PRReleasevia Quantisnow
ARCA biopharma Inc. logo

ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
ABIO· ARCA biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABIO (ARCA biopharma Inc.) and more on Quantisnow.